Access to MAT: Dollars and sense
Alcoholism & Drug Abuse Weekly · 23.02.2026 · 38 (8) · 7-7
DOI: 10.1002/adaw.34820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcoholism & Drug Abuse Weekly, online erschienen am 23.02.2026. Verfasst von Rob Kent.
Abstract (Originalsprache)
I am proud that when I worked at the White House Office of National Drug Control Policy, we worked together with Congress to pass the Modernizing Addiction Treatment (MAT) Act, which eliminated the X‐waiver that required prescribers to obtain additional Drug Enforcement Administration (DEA) approvals to prescribe buprenorphine for addiction treatment. (As an aside, the DEA is trying to create “son of the X‐waiver” in the context of their telemedicine special registry, but that is for another commentary).
Zitieren
APA
Kent, R. (2026). Access to MAT: Dollars and sense. Alcoholism & Drug Abuse Weekly, 38(8), 7-7. https://doi.org/10.1002/adaw.34820
Vancouver
Kent R. Access to MAT: Dollars and sense. Alcoholism & Drug Abuse Weekly. 2026;38(8):7-7. doi:10.1002/adaw.34820
BibTeX
@article{Kent2026,
author = {Kent, Rob},
title = {Access to MAT: Dollars and sense},
journal = {Alcoholism & Drug Abuse Weekly},
year = {2026},
volume = {38},
number = {8},
pages = {7--7},
doi = {10.1002/adaw.34820}
}
EUVIMED